1. Home
  2. |Insights
  3. |COVID-19 Business Interruption: Financial Conduct Authority Test Case Ruling Expected on Friday

COVID-19 Business Interruption: Financial Conduct Authority Test Case Ruling Expected on Friday

Client Alert | 1 min read | 01.13.21

The U.K. Supreme Court has announced that on Friday, January 15, 2021 it will hand down its decision in the Financial Conduct Authority (FCA)) v Arch Insurance (UK) Ltd., et al. matter (known as the FCA “test case”). The case concerns the construction of certain insurance policy provisions that purport to provide coverage in the event of business interruption. The Court below considered the construction of each policy wording and the FCA, the Appellant Insurers and the Hiscox Interveners appeal on a number of points.

Broadly speaking, the Supreme Court is asked to determine:

  1. certain matters of construction relating to:
    1. "Disease Clauses" (i.e. those which can be triggered by the occurrence of severe acute respiratory syndrome coronavirus 2 ("COVID-19"), typically within a specified distance of the insured’s premises);
    2. "Prevention of Access Clauses" (i.e. those triggered by public authority intervention preventing access to, or use of, premises as a result of COVID-19); and
    3. "Hybrid Clauses" (i.e. those clauses which contain wording from both Disease and Prevention of Access Clauses), and
  2. whether the Court below was correct:
    1. to apply certain counterfactual scenarios in relation to the operation of the clauses in relevant policies which provided for loss adjustments (the "Trends Clauses"); and
    2. in its analysis of Orient-Express Hotels Ltd v Assicurazioni Generali S.p.A.

After the Supreme Court’s opinion is released, Crowell & Moring LLP will provide a summary of the ruling, which concerns wordings distinct from those typically being litigated in the COVID-19 related business interruption cases across the United States.

Insights

Client Alert | 3 min read | 07.08.25

DOJ and HHS Launch FCA Working Group: Heightened Enforcement Risk for Health Care Entities

On July 2, 2025, the U.S. Department of Justice (DOJ) Civil Division and the U.S. Department of Health and Human Services (HHS) jointly announced the formation of a False Claims Act (FCA) Working Group. This new initiative underscores a coordinated federal enforcement strategy focused on identifying and addressing fraud in federally funded health care programs, particularly Medicare Advantage and Medicaid managed care. The announcement comes days after Matthew R. Galeotti, Head of DOJ’s Criminal Division, announced the results of the “largest coordinated health care fraud takedown in the history of the Department of Justice”  and the creation of a “Health Care Fraud Data Fusion Center” comprised of data specialists that will “break down information silos, using coordinated data analysis to enable our investigative teams to quickly identify and dismantle emerging fraud schemes.” Taken together, these announcements demonstrate the DOJ’s effort—in both civil and criminal divisions—to strengthen its collaboration with HHS to investigate and prosecute health care fraud....